Agenus to Present Phase II Data on Novel BOT+BAL and agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 Agenus a biotechnology company focused on advancing immuno-oncology therapies, has announced that new clinical data from an investigator-initiated Phase II…
After an Autism Diagnosis: A Guide for Families Navigating the Next Steps April marks Autism Acceptance Month, a time dedicated not only to raising awareness but also to promoting understanding, inclusion, and advocacy for individuals with autism. The month begins…
GenSight Biologics Confirms Full-Year 2025 Financial Results in Line with Prior Estimates GenSight Biologics a clinical-stage biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has confirmed that its final consolidated financial results…
Allevion Medical Secures FDA Clearance for Vantage™ Disposable System for Spinal Decompression Allevion Medical has announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its innovative Vantage™ system, a fully disposable and sterile solution designed…
Spacelabs Healthcare Partners with DEPTH Health to Expand Access to Rothman Index® for Hospitals Spacelabs Healthcare has announced a strategic agreement with DEPTH Health, Inc. aimed at enhancing clinical decision-making and patient care across hospitals and health systems. Through this…
Powering PREVOYANCE® with Advanced Image Signal Processing Capabilities A correction has been issued regarding the original press release published on March 31, 2026. In the second paragraph, the certification previously listed as ISO 13585 has been corrected to ISO 13485,…
VDYNE Secures FDA IDE Approval to Advance Pivotal TRIVITA1 Trial for Transcatheter Tricuspid Valve Replacement System VDYNE, Inc., a privately held medical device innovator focused on next-generation transcatheter valve therapies, has achieved a major regulatory milestone with the approval of…
SCP Health Expands Performance Edge Model to Strengthen Hospital-Based Care Hospitals across the United States are navigating an increasingly complex healthcare environment marked by workforce shortages, financial pressures, and rising administrative demands. In response to these challenges, SCP Health, a…
RefleXion Expands Medicare Reimbursement for SCINTIX Therapy Across Majority of U.S. Regions RefleXion Medical has announced a significant advancement in expanding access to its innovative SCINTIX® autonomous radiotherapy, as another Medicare Administrative Contractor (MAC), Noridian Healthcare Solutions, LLC, has approved…
Zentist to Host Dental RCM Bootcamp 6.0 in Nashville, Bringing Together Industry Leaders for Advanced Revenue Cycle Insights Zentist has officially announced that its highly anticipated Dental RCM Bootcamp 6.0 will take place from August 30 to September 1, 2026,…
Cencora to Release Second Quarter Fiscal 2026 Results on May 6, 2026 Cencora, Inc. has officially announced the date and time for the release of its financial results for the second quarter of fiscal year 2026. The company will publish…
Alpha Cognition Secures U.S. Patent for ALPHA-1062 in Traumatic Brain Injury, Expanding Pipeline Potential Alpha Cognition Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases, has announced a significant milestone in its intellectual property strategy. The…